Why we need to know the limitations of evidence-based medicine

Consultant

Volumn 46, Issue 9, 2006, Pages 963-

  Rutecki, Gregory W ^a,b,c,d  

^a OHIO STATE UNIVERSITY   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c MOUNT CARMEL HEALTH SYSTEM   (United States)

^d WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; COMORBIDITY; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; HEART DISEASE; HYPERLIPIDEMIA; KIDNEY DISEASE; LUNG DISEASE; NOTE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RHEUMATIC DISEASE;

EID: 33748055130     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (6)

1. Fortin M, Bravo G, Hudon C, et al. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005;3:223-228.
2. Fortin M, Dionne J, Pinho G, et al. Randomized controlled trials: do they have external validity for patients with multiple comorbidities? Ann Fam Med. 2006;4:101-103.
3. Appel LJ, Champagne CM, Harsha DW, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289:2083-2093.
4. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755-1762.
5. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA. 2002;288:2981-2997.
6. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-10.